Alpha Tau completes enrollment in pivotal skin cancer trial

May 8, 2026 9:00 AM

Alpha Tau Medical Ltd. (NASDAQ: DRTS) announced completion of patient enrollment in its ReSTART pivotal trial, a U.S. multicenter study ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found